Dairy-like compositions and related methods
US-2024114916-A1 · Apr 11, 2024 · US
US2021196804A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2021196804-A1 |
| Application number | US-201917269951-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 21, 2019 |
| Priority date | Aug 22, 2018 |
| Publication date | Jul 1, 2021 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Sucrose isomerase is used as a nutritional supplement, or can be mixed in with a powderous food/beverage formulation. When an animal, including a human, consumes sucrose, the sucrose isomerase will act on the sucrose present in the food, and will convert the sucrose to other sugars. This results in lowering of the glycemic index of the food without changing the formulation of the food.
Opening claim text (preview).
1 . A nutraceutical, pharmaceutical or nutritional supplement composition comprising a sucrose isomerase. 2 . A composition according to claim 1 which is suitable for humans. 3 . A composition according to claim 2 which is suitable for companion animals. 4 . A composition according to claim 1 comprising a sucrose isomerase with at least 60% identity, preferably 90%, 95%, 98%, 99%, 100% identity, to any one of the sequences of SEQ ID NO:1-6. 5 . A composition according to claim 4 comprising a sucrose isomerase with at least 60% identity, preferably 90%, 95%, 98%, 99%, 100% identity, to SEQ ID NO: 4. 6 . A method of lowering the increase of blood glucose levels in an animal, including a human ingesting sucrose, comprising administering a nutraceutical, pharmaceutical or nutritional supplement of claim 1 to the animal including a human in need thereof. 7 . A method of lowering the glycemic index of a food or feed which is consumed by a human or companion animal comprising administering to the human or companion animal a nutraceutical, pharmaceutical or nutritional supplement comprising a sucrose isomerase according to claim 1 . 8 . A method of losing weight or maintaining weight loss in a human or companion animal comprising administering to the human or companion animal a nutraceutical, pharmaceutical or nutritional supplement comprising a sucrose isomerase according to claim 1 . 9 . Use of a nutraceutical, pharmaceutical or nutritional supplement comprising a sucrose isomerase to achieve a condition in an animal, including a human, selected from the group consisting of: a) lower the increase of blood sugar levels; b) increased endurance of an animal performing endurance exercise; c) loss of weight, or maintenance of lost weight d) lowering the glycemic index of ingested food or feed; and e) sustained energy release and/or prevention or minimization of a fast blood sugar rise and the so-called after-meal “dip” after a sucrose-containing meal. 10 . A dry food or beverage mixture comprising a sucrose isomerase.
Enzymes · CPC title
Promoters of weight control and weight loss · CPC title
Proteins from microorganisms · CPC title
Isomerases (5) · CPC title
Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.